Abstract:Objective:To evaluate the role and clinical outcome of extracorporeal membrane oxygenation (ECMO) as circulatory support bridging to heart transplantation.Methods:The clinical data of 96 recipients who underwent heart transplantation in the Department of Cardiovascular Surgery, the First Affiliated Hospital, College of Medicine, Zhejiang University from March 1st, 2019 to August 31, 2022 were retrospectively analyzed. All 96 recipients were divided into the ECMO group (n=33) and the non-ECMO group (n=63) based on whether received ECMO as circulatory support. To compare continuous variables between groups, the unpaired Student′s t-test was used if the continuous data were normally distributed, while the Mann-Whitney U test was used when the continuous data were non-normally distributed. Chi-square test was used to compare categorical variables. Kaplan-Meier survival analysis was performed to make survival curves and were compared by using log-rank test. P<0.05 was considered statistically significant.Results:The circulatory support time in the ECMO group was 9.29 (3.23, 20.81) d and 6 recipients in the ECMO group also received percutaneous balloon atrial septostomy. There were statistical difference for the indexes of recipients including the waiting-list time, C-reactive protein, very-low-density lipoprotein, high-density lipoprotein, uric acid, AST, ALT, total bilirubin, history of cardiopulmonary resuscitation, history of pacemaker implantation, history of cardiac surgery and primary heart disease between the two groups (Z=438.50, 1 564.00, 900.00, 109.00, 1 583.50 and 1 556.50, t=2.28 and 1 157.50, χ2=32.29, 6.10, 9.87 and 18.24, all P<0.05). Moreover, the indexes including the cold ischemic time, cardiopulmonary bypass time, aortic clamping time, intraoperative red blood cell transfusion, intraoperative plasma infusion, intensive care unit stay time, mechanical ventilation time and postoperative ECMO application of recipients were statistically different between the two groups (Z=1 405.5, 1 235.5, 1 437.5, 1 192.5, 981.0, 1 567.5 and 1 587.0, χ2=28.46, all P<0.05). There were 19 recipients (57.6%) received ECMO postoperatively, which was statistically higher than that in the non-ECMO group (5 cases, 7.9%) (χ2=28.46, P<0.05). Compared with the non-ECMO group, the ECMO group had higher 30-day mortality (15.2% vs 3.2%, χ2=4.595, P<0.05), higher in-hospital mortality (21.2% vs 6.3%, χ2=4.715, P<0.05) and higher 1-year mortality (30.3% vs 11.1%, χ2=5.474, P<0.05). There was statistical difference for the cumulative survival rate between the ECMO group and the non-ECMO group (χ2=4.650, P<0.05). After excluding the death cases within 30 days after transplantation, there was no significant difference for the cumulative survival rate between the two groups (χ2=1.140, P>0.05).Conclusions:Although the overall prognosis patients with ECMO bridged heart transplantation recipients is worse than that of non-bridged recipients, it is still an effective treatment for patients with irreversible cardiogenic shock. Effective preoperative evaluation, well perioperative management and individualized postoperative anti-rejection treatment can further improve the long-term prognosis of ECMO bridged heart transplantation.

Impact of left ventricular unloading on postheart transplantation outcomes in patients bridged with VA-ECMO

Association of Pulmonary Artery Pressure Change with Post-Lung Transplantation Survival: Retrospective Analysis of China Registry

Novel Left Ventricular Unloading Strategies in Patients on Peripheral Venoarterial Extracorporeal Membrane Oxygenation Support

Comparative Temporal Analysis of Morbidity and Early Mortality in Heart Transplantation with Extracorporeal Membrane Oxygenation Support: Exploring Trends over Time

Veno‐arterial ECMO ventricular assistance as a direct bridge to heart transplant: A single center experience in a low‐middle income country

Left ventricular unloading in patients supported with veno-arterial extra corporeal membrane oxygenation; an international EuroELSO survey

ECMO LENS preliminary data, a retrospective LV unloading study: focus on LV unloading indications

Does left ventricular assist device implantation volume affect post-cardiac transplant outcome? an analysis of the united network for organ sharing (UNOS) thoracic registry

Impact of Extracorporeal Membrane Oxygenation Bridging Duration on Lung Transplant Outcomes

Different strategies in left ventricle unloading during venoarterial extracorporeal membrane oxygenation: A network meta-analysis

Ambulatory Extracorporeal Membrane Oxygenation Use in Patients Listed for Lung Transplant

Left ventricular unloading during veno-arterial ECMO: a review of percutaneous and surgical unloading interventions

The Conversional Efficacy of Ex Vivo Lung Perfusion and Clinical Outcomes in Patients Undergoing Transplantation of Donor Lungs by Ex Vivo Lung Perfusion: A Meta-Analysis.

Predictors of outcome among patients on extracorporeal membrane oxygenation as a bridge to lung transplantation

Impact of Heart Failure Etiology on Waitlist Mortality in Heart Transplant Candidates Supported With Extracorporeal Membrane Oxygenation

Impact of bridging veno-venous extracorporeal membrane oxygenation to COVID-19 lung transplantation

Extracorporeal membrane oxygenation as circulatory support bridging to heart transplantation: a single center experience of 33 cases

Mechanical left ventricular unloading in cardiogenic shock treated with venoarterial extracorporeal membrane oxygenation: a systematic review and meta-analysis

Effect of transplant center experience on post-transplant mortality for patients supported with an implantable left ventricular assist device: an analysis of the united network for organ sharing (UNOS) thoracic registry

Veno-Arterial Extracorporeal Membrane Oxygenation for Patients Undergoing Heart Transplantation: A 7-Year Experience

Reversibility of Precapillary Pulmonary Hypertension and Outcomes After Heart Transplantation Bridged with Left Ventricular Assist Devices: Insight from the UNOS